The recent surge of interest in isolated human populations can be attributed largely to the advances in molecular genetics that now appear to produce an endless array of new data. However, the organised study of inherited traits and disorders in isolated populations started several decades ago. For example, at the beginning of the second half of this century several enthusiastic investigators at the Department of Paediatrics, University of Helsinki began to document rare diseases in Finns that either had not been previously described or were very rare elsewhere. The 'flagship' disease was congenital nephrosis described by
Hallman et all and established as an autosomal recessive disorder by Norio.2 These were the heydays of biochemical genetics. Rapidly, as many as a dozen rare disorders, many of which were 'metabolic', were found with a high frequency in Finns. A landmark paper by Norio et aP carrying the title Hereditary diseases in Finland; rare flora in rare soil was published in 1973; it described 10 'Finnish' disorders. Another landmark paper had appeared a year earlier describing extensive blood group and serum marker studies in conjunction with genealogical features of the Finnish population. 4 Further studies by Nevanlinna and his group have characterised the Finnish gene pool and offered interpretations regarding the Finnish population history and structure. 5 8 The following is a brief review of 'Finnish' disease genes and the lessons that have been gained so far from their molecular study. A Archaeological and historical documentation conclusively shows that the founding popula- 2) shows that the founder lived in one of two nearby parishes in southern Finland and a combination of genealogical and historical data led Meretoja2526 to speculate that the founder may have lived in the 1200s; some 1000 persons are probably affected today. After it had been shown that the amyloid was derived from gelsolin (GSN), the mutation (Aspl87Asn) in the Finnish population was established27 28 and it was shown that it is caused by a G654A substitution in GSN.29 As expected, all Finnish patients studied so far carry the same mutation."03 Available evidence suggests that the disease is exceedingly rare, as fewer than 10 pedigrees comprising in total fewer than 40 affected subjects have been published worldwide. When the first two non-Finnish families had been tested (both living in the USA) and both had displayed the G654A mutation,3032 the hypothesis was put forward that most or all living patients world wide shared one ancestral mutation. However, another mutation, G654T, was subsequently found in a Danish and a Czech pedigree, and as these mutations occurred on different intragenic haplotypes it became evident that there had been more than one or two independent mutations.30 Moreover, as no mutations have so far been detected other than in nucleotide 654 (amino acid 187), it appears that specific alterations of this residue of the gelsolin molecule may predomi- Definitive proof had to await the unravelling of the mutations themselves. It was first shown that all members of the Salla pedigree had the same unique mutation, CHM*SAL, consisting of an insertion of a T into a splice donor site leading to the transcriptional skipping of one exon followed by premature termination of translation.' This mutation occurred in neither the Kainuu nor the Tornio patients, nor in two apparently unrelated patients from southern Finland. More recent data show that the mutations in Kainuu and Tornio do indeed differ from each other." Thus, in the small (500 000 persons) and isolated northem Finnish population, three different CHM mutations occur. While this high figure is possibly the result of chance alone, it needs to be considered that the frequency of three CHM mutations in a population of 500 000 corresponds to 30 CHM mutations in Finland (eight known) and 1800 in the USA (some 20 unrelated patients published so far).
Linkage disequilibrium in a recently founded population
The data in table 3 show almost total linkage disequilibrium between CHM and an extended RFLP haplotype within each of the three districts in northern Finland. This is remarkable as the genetic distance between the haplotype's outermost loci is of the order of 9 cM. 42 While linkage disequilibrium in large panmictic populations rarely, if ever, is discernible at genetic distances exceeding 1 cM,45 we show empirically here that, as expected, recently founded populations will show linkage disequilibrium over much longer stretches of DNA. As will be detailed below the genetic distances between loci can be calculated based on linkage disequilibrium as long as the population fulfils certain criteria. In this case the crucial point is the number of generations since the founding. Based on the genealogical evidence on CHM in Salla it was calculated that only a total of 105 female meioses were needed to transmit CHM* SAL from the putative founder to the youngest present day generation that was tested.4' This explains why, over a stretch totalling some 9 cM, very few recombinations have occurred (three documented by the study of 65 affected chromosomes).
A similar situation prevails regarding retinoschisis (RS), another X linked recessive disorder causing progressive loss of vision in affected males. There are some 300 affected males in Finland (until recently the total number described in the rest of the world was less than 200, but this may be mainly because of diagnostic difficulties"3). The disease occurs in two main geographical clusters in Finland, in a densely populated region on the southwestern coast, and in the sparsely populated north-central part of the country (fig 4) . 20 generations.
In conclusion, linkage disequilibrium can be a major tool in the study of genes in isolated populations. As long as the number of generations since the founding is known, linkage disequilibrium can be used to assess the number of different mutations as well as genetic distances between loci. Conversely, if the genetic marker map is well characterised, the extent of linkage disequilibrium can be used to determine the number of generations since the founding.
Autosomal recessive founding mutations Most of the autosomal recessive disorders that are common in Finland (table 1) occur with low frequency in other populations. Therefore the mutation rates of these genes are low and the high gene frequency in Finland is because of the chance inclusion or occurrence of one mutation in the small founding population followed by enrichment through genetic drift in the population that expanded while isolated. Repeated sampling within Finland in the form of bottlenecks and chance events contributed to the drift. 6 for a rare disease locus like DTD. The number of generations (g) since founding is approximated at 100. Finally, the overall disease gene frequency q can be calculated based on the frequency of newborn affected homozygotes; q for DTD is estimated at 0-008. 47 With these approximations the value of a is 0 94. In other words, out of 80000 DTD bearing chromosomes in Finland, only 6% or some 5000 are the result of new mutations or immigration while the remaining 94% all descend from the original founder. Table 5 lists the pertinent corresponding figures for four recessively inherited 'Finnish' disorders. The recent cloning of the AGA and OAT genes harbouring the disease causing mutations has allowed these mutations to be characterised so that the actual proportion of the main ancestral founding mutation is known. The numbers calculated in the way indicated above show good correlation with the actual ones (AGA: calculated 96%, observed 98%; OAT 90% v 85%). For the remaining two diseases (DTD and EPM1) the genes have not yet been cloned so the mutations are unknown. Since in both cases the cloning of the gene is being actively pursued,4792 it will no doubt soon be possible to know how right or wrong the calculations are. Finnish CF chromosomes (45%) carry the major AF508 mutation, which has led to speculation about another major mutation being a possibility.58 Such a mutation (394delTT) was recently discovered in 12 Finnish CF chromosomes, thus accounting for 30% of all CF mutations in the country.59 Mutation 394delTT is also common in Scandinavia,60 it is rare in western Europe, while its frequency in Russia and the rest of eastern Europe remains to be determined. If it turns out to be common in the east, one might postulate that it spread to Scandinavia via Finland; if not, it may have a Scandinavian or Finnish origin.
CALCULATING GENETIC DISTANCES BETWEEN DISEASE GENE AND MARKER LOCUS BASED
As described by Norio"0 several well known recessively inherited diseases have apparently never been diagnosed in Finland. These include galactosaemia, maple syrup urine disease, cystinosis, histidinaemia, and Pendred syndrome. Other disorders that are so rare in Finns that they have been diagnosed only once or twice include Tay-Sachs disease, Gaucher disease, Hartnup disease, Fabry disease, and several glycogenoses.
In summary, the hypotheses regarding how certain rare disease mutations became highly enriched in Finland are amply supported by the fact that other rare disease mutations are extremely rare in Finland.
Medical and social ramifications
The impact of hereditary disorders on health care increases dramatically in modern medicine. Whenever a rare disorder is enriched in a population it is important that physicians are well informed about its existence, under what circumstances to expect it, and how to diagnose it. Many of the disorders described here are amenable to treatment if diagnosed in time. A single example, congenital chloride diarrhoea (CLD), will be mentioned. The main presenting symptom, watery diarrhoea in an infant, is so common that CLD will often be missed; however, when CLD is suspected the diagnosis is readily made by showing high chloride concentrations in the stools, and the life threatening condition is treated by chloride supplementation. As shown on the map of Finland ( fig 5) the disease mainly occurs in the sparsely populated east central part of the country, where its incidence is high. As the disorder has been extensively studied it has also been the object of numerous seminars and presentations, particularly in the affected part of the country. As a result, its diagnosis and therapy pose few problems. Moreover, research into various aspects of the disease is facilitated by the high degree of ascertainment that follows from public and professional awareness of it.
It appears that family and patient acceptance, and participation in research, and therapeutic and preventive trials are all enhanced by the public recognition that a particular disorder occurs more commonly than elsewhere. As pointed out by Vogel and Motulsky,6' in relatively centralised health care systems of high quality, both the medical care and the scientific study of rare hereditary disorders can be vigorously pursued.
